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THE ROLE OF THE RESPIRATORY MUCOSAL IMMUNITY I N  P ROTECTION 
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Pneumonic pasteurel losis is one of the most important and devastating 
d iseases i n  sheep and goats ,  causing great economic losses to smal l  ruminant 
industry worldwide. The d isease is caused either by Pasteurella haemolytica or 
Pasteurella multocida and Pasteurella haemolytica A2 is the most common 
isolate from sheep and goats in Malaysia, comprising approximately 38 per cent 
of the isolates from pneumonic lung lesions. 
The d isease is best control led by vaccination, and systemic vaccination 
has been used for years with l imited success. Stress, improper vaccination 
program and unpopularity of the vaccine among the farmers are some of the 
xii 
reasons that have been associated with the persistence of the disease. S ince 
the systemic vaccination fai led to give promising results , studies on the role of 
mucosal immunity of the respiratory tract in control l ing pneumonic pasteurel losis 
should t imely be reviewed. 
In  this study, the bronchus-associated lymphoid tissue (SALT) in the 
lungs 9 been successful ly stimulated by double intranasal exposures to either 
l ive or formal in-kil led Pasteurella haemolytica A2 at two weeks interva l .  The 
size of SALT and number of lymphocytes in the SALT were significantly 
increased as early as week 2 post-exposure and remained h igh unti l  week 4 
post-exposure. At the same time, the level  of IgA against Pasteurella 
haemolytica A2 increased significantly as early as week 1 post-first exposure 
and reached a peak level at week 6 post-exposure. The IgM appeared to be 
present for a short wh i le, at week 3 post-exposure before the levels started to 
decline in the fol lowing week. Initially, the IgG increased gradual ly and 
insignificantly before it reached significantly h igh level at week 4 post-exposure, 
and remained h igh at weeks 5 and 6 at the time when the numbers of SALT 
continued to increase.  
Th is study a lso revealed that intranasal stimulation of SALT was ab le to 
protect the lungs from colonization by Pasteurella haemolytica A2 during an in 
vitro study, thus prevent the lung surface from being adhered and invaded by 
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the organism. However, dexamethasone treatment which is similar to the effect 
of steroid released under stressful conditions, significantly reduced the number 
and size of the SALT, thus significantly reduced the percentage of IgA-producing 
cel ls .  
Vaccination tria l  on goat farm using the pasteurel la spray vaccine 
intranasal ly showed good protection towards pneumonic pasteurel losis. 
Significant high levels of systemic antibody responses were also noted during 
the period of vaccination tria l .  The incidence of pneumonic pasteurel losis in the 
farm was markedly reduced. 
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Pasteurel losis pneumonia adalah salah satu penyakit terpenting pada 
kambing dan bebiri , mengakibatkan kerugian ekonomi yang nyata pada industri 
ruminan keci l serata dunia. Penyakit ini disebabkan oleh sama ada Pasteurella 
haemolytica atau Pasteurella multocida, dan Pasteurella haemolytica A2 
merupakan isolat yang pal ing kerap diasingkan daripada kambing dan bebiri d i  
Malaysia ,  merangkumi kira-kira 38 peratus isolat yang d iperolehi daripada lesi 
pneumonia. 
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Penyakit ini boleh dikawal dengan baik melalui pemvaksinan, dan 
pemvaksinan sistemik telah digunakan selama bertahun-tahun dengan 
kejayaan yang terhad.  Ketegasan ,  program pemvaksinan yang tidak sesuai dan 
ketidakpopularan vaksin di  kalangan penternak adalah antara sebab-sebab 
yang dikenalpasti menyebabkan penyakit ini berterusan. Memandangkan 
selama ini pemvaksinan sistemik gagal untuk membuahkan hasil yang 
memuaskan, sudah sampai masanya kajian ke atas peranan keimunan 
mukosal pada trakus pernafasan dalam mengawal radang peparu pasteurel losis 
dipertimbangkan semula . 
D alam kajian ini, tisu l imfoid berkait bronkus (BAL T) dalam peparu telah 
berjaya dirangsangkan melalui dedahan berganda kepada Pasteurella 
haemolytica A2 yang  hidup atau dimatikan dengan formalin mela lui  intranasal . 
Dedahan berganda dibuat dalam jangkamasa selang 2 minggu. Saiz BAL T dan 
bilangan sel l imfosit dalam BAL T bertambah dengan ketara seawal 2 minggu 
selepas dedahan, dan mengekalkan ketinggiannya sehingga minggu ke 4 
selepas dedahan. Pada masa yang sama, tahap IgA terhadap Pasteurella 
haemolytica A2 meningkat dengan ketara seawal minggu pertama selepas 
dedahan,  dan mencapai kemuncaknya pada minggu ke 6 selepas dedahan. 
IgM hadir cuma sebentar, iaitu pada minggu ke 3 selepas dedahan,  sebelum 
menurun pada minggu berikutnya. Pada peringkat awal ,  IgG meningkat 
beransur-ansur sebelum mencapai peningkatan bermakna pad a minggu ke 4, 
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dan mengekalkan ketinggiannya pada minggu ke 5 dan 6, iaitu masa di  mana 
bilangan SALT turut meningkat. 
Kajian ini juga  menunjukkan bahawa rangsangan melalui intranasal ke 
atas SALT mampu melindungi peparu daripada dikoloni oleh Pasteurella 
haemolytica A2, seterusnya menghalang permukaan peparu daripada dilekati 
dan dicerobohi organisma berkenaan. 
Walau bagaimanapun ,  rawatan oleh dexamethasone yang mempunyai 
kesan yang sama seperti steroid sewaktu tegasan, mengurangkan bilangan dan 
saiz SALT dan turut mengurangkan peratusan sel yang menghasilkan IgA. 
Pemvaksinan yang dilakukan di ladang ternakan kambing menggunakan vaksin 
semburan intranasal menghasilkan perlindungan yang baik terhadap penyakit 
pasteure l losis pneumonia. Gerakbalas antibodi sistemik yang tinggi dan ketara 
di dapati berlaku sewaktu kajian dija lankan Pengurangan kadar penyakit 
pasteurel losis pneumonia d i  ladang berkenaan juga dapat dil ihat dengan jelas. 
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CHAPTER 1 
I NTRODUCTION 
Pneumonic pasteure l losis is one of the most important and 
devastating d iseases affecting smal l  ruminants worldwide. The disease is 
caused by either Pasteurella haemolytica or Pasteurella multocida 
(Donach ie, 1 993), although the former is frequently isolated from such cases 
in goats (Gi lmour, 1 992). 
There are two biotypes of Pasteurella haemolytica , namely biotype A 
and T. C l inical ly,  biotype A is associated with pneumonic pasteurel losis and 
comprises serotypes 1 ,  2 ,  5 ,  6 , 7 , 8 , 9 , 1 1 , 1 2 , 1 3 , 1 4  and 1 6. B iotype T, that 
comprises serotypes 3, 4, 1 0  and 1 5 , is associated with systemic d isease in 
young lambs. About 1 0  percent of the Pasteurella haemolytica serotypes 
remain untypable (Donachie, 1 993) . The development of the disease has 
been known to be associated with various stress factors particularly the 
environmental factors such as cl imate, transportation ,  nutrition and housing 
(Jubb ef a/. , 1 985; Zamri-Saad ef a/. , 1 989; Jasni ef a/. , 1 99 1 ) .  Concurrent 
infections with parainfluenza type I I I  virus, herpesvirus and Haemonchus 
contortus have also been shown to predispose animals to pneumonic 
pasteure l losis (Gi lmour et aI. , 1 993; Zamri-Saad et aI. , 1 993a). 
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Various studies have been conducted regarding the use of vaccines to 
control pneumonic pasteurel losis in Malaysia (Zamri-Saad et al. , 1 989; 
Chandrasekaran et al. , 1 99 1 ;  Zamri-Saad et al., 1 993b) however the results 
were inconclusive and the disease remains a major threat to the goat and 
sheep industry. Imported vaccines, such as HEPTAVAC-P (Hoechst, UK) , 
Ovipast (Hoechst (M) Sdn. Bhd.)  and Carovax (Wellcome, UK) have been 
used to control the disease with l imited success rate (Wan Mohamed et al., 
1 988). A locally produced formalin-killed oil adjuvant vaccine, incorporating 
Pasteurella haemolytica and Pasteurella multocida of unknown serotypes 
was also used unsuccessful in control ling the disease (Zamri-Saad et aI. , 
1 989). However, an improved oil adjuvant vaccine that incorporating the 
locally isolated Pasteurella haemolytica A 7 and Pasteurella multocida types 
A and 0 showed ability to protect the lambs when challenged with either 
Pasteurella haemolytica A2 or A7 (Zamri-Saad et al. , 1 993b). Although the 
local ly produced oil adjuvant vaccine gave better protection ,  its thick 
viscousity lead to difficulties in administration and caused swel l ing at the site 
of administration and lameness with uneventful recovery in approximately ten 
percent of vaccinated animals (Jamaludin, 1 993). 
The locally produced oil adjuvant vaccine has been shown to be able 
to stimulate good antibody response (Zamri-Saad et aI. , 1 993c). However, 
most sheep in various farms in Malaysia showed low antibody titre against 
pasteurel losis (Zamri-Saad et al. 1 993d) and does not protect the animal  
from being contacted with pneumonic pasteurel losis , thus the disease 
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incidence remained h igh in many farms. This is probably due to the 
unpopularity of the oil adjuvant vaccine among farmers (Jamaludin, 1 993) 
and the improper vaccination program provided by the vaccine manufacturer, 
which has been recognised as one of the contributing factors in vaccination 
fai lure (Zamri-Saad , 1 996). 
The respiratory tract, wh ich is the route of infection for Pasteurella 
haemolytica (Gi lmour et al. ,  1 991 ) ,  is one of the mucosal tissues in  the body 
which armed with mucosal immunity (Kaltrieder, 1 976) . Anderson et al. 
( 1 986) stated the importance of stimulating the pulmonary lymphoid tissue 
with effective methods that wi l l  provide substantia l  local cel lular and antibody 
mediated immune responses (Kaltrieder, 1 976). 
Other factors that contribute to the success of vaccination include the 
method of vaccine administration (Mosier, 1 993) . Thus, with the uncertainties 
and d ifficulties encountered in systemic vaccination of animals against 
pneumonic pasteurel losis, other methods for the control of pneumonic 
pasteure l losis should perhaps be explored . 
The objectives of this study are :  
1 .  to stimulate the mucosal immunity in  the respiratory tract of goats 
fol lowing either with intranasal or oral exposures to Pasteurella 
haemolytica A2. 
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2. to determine the mucosal immune responses fol lowing intranasal 
exposures to formalin-ki l led Pasteurella haemolytica A2. 
3. to verify the immunosuppresive effect of dexamethasone on mucosal 
immunity of the respiratory tract fol lowing intranasal exposure to 
formal in-ki l led Pasteurella haemolytica A2. 
4. to determine the protective role of mucosal immunity against 




Pasteurella haemolytica is a Gram-negative, smal l ,  non-motile ,  cocco­
bacil lus bacteria with slight  pleomorphism and occasional bipolar staining 
(Adlam , 1 989). The organism can easily be recognised upon cultivation on blood 
agar and show various sizes of beta zone haemolysis.  Bovine blood appears to 
be superior for the demonstration of the organism when compared with ovine or 
horse blood (Soltys , 1 979). 
The organism can be separated into two biotypes, A and T (Donachie, 
1 993). Biotypes A and T from cases of ovine pneumonia can be distinguished 
based on different cul tura l ,  biochemical and pathological characteristics (Soltys , 
1 979) . De Alwis ( 1 993) recorded that the differences between biotypes A and T 
depend on their abil ity to ferment arabinose and not trehalose and vice versa. 
Both serotypes are heterologus in nature and sixteen serotypes can be 
differentiated by an indirect haemagg lutination ( IHA) test which distinguishes 
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sixteen different capsular antigens in the two biotypes (Donachie, 1 993) . 
Biotype A comprises serotypes 1 ,  2, 5, 6, 7, 8, 9, 1 1 , 1 2, 1 3 , 1 4  and 1 6, while 
the biotype T contains serotypes 3, 4, 1 0  and 1 5. Ten percent remain untypable 
(Donachie, 1 993). 
Al l serotypes are pathogenic and serotype A2 is the most prevalent, 
comprises around 38% of a l l  Pasteurella haemolytica isolates (Donachie, 1 993). 
The most common serotypes isolated from pneumonic pasteurel losis of sheep 
and goats in Malaysia are serotypes A2, fol lowed by A7 and A9 (Bahaman et al. , 
1 991 ) .  Pasteurella haemolytica serotypes A 1 1  and A 1 2  were also isolated from 
cases in Malaysia (Bahaman et al. , 1 99 1 ) . 
Pneumonic Pasteurel losis 
Pasteurella haemolytica can be found in nasopharynx of healthy animals 
as normal  flora (Gilmour, et al. , 1 99 1 ;  De Alwis, 1 993). Although the organism 
are present in the nasopharynx area, the animal are not clinical ly affected with 
pneumonic pasteurellosis (Mosier, 1 993). Colostral immunity in lambs can last 
for approximately 4 to 5 weeks (Gilmour and Gilmour, 1 989), but the duration of 
immunity fol lowing natura l  infection has not been ful ly investigated adequately 
(Mosier, 1 993). The prevalence of respiratory infections and associated 
economic losses continues to be very high although various attempts have been 
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made to control the d isease. It is difficult to control respiratory disease since 
respiratory infections often occur as a resul t  of synergistic interactions between 
various pathogens (Busse, 1 99 1 ) . Many carriers of Pasteurella haemolytica wi l l  
not a lways develop pasteurel losis and remained cl inical ly healthy (Gi lmour  and 
Gi lmour, 1 989) . This is because the exposure of respiratory pathogenic 
organism per se is  not sufficient enough for the development of disease. 
Furthermore, the respiratory tract provides a variety of integrated defence 
mechanisms including mechanical non-immunological and immunologica l ,  which 
function in  concert to prevent development of respiratory tract infections 
(Stratton, 1 986) .  However, fai lure of any one or more of the lung defence 
mechanisms d isrupts th is stage of homeostasis resulting in pulmonary infection 
(Babiuk and Campos, 1 993). 
Various stress factors such as transportation, cl imate and housing stress 
(Jubb, et aI. , 1 985; Zamri-Saad , et al. , 1 989; Jasni , et al., 1 991 ) could alter  the 
normal homeostasis of the host. This favour the organism in such a way that i t  
repl icates much h igher levels and migrates to the lower lung without being 
cleared by the normal defence mechanisms. The prevalence and numbers of 
Pasteurella haemolytica in the nasopharynx increase during stressful conditions, 
predisposing the h ost to pneumonic pasteurel losis (Gi lmour, 1 993). Outbreaks 
of the d isease usually are sporadic and unpred ictable (De Alwis, 1 993; Gi lmour, 
1 989) and is unl ikely to develop a long lasting flock resistance in the farm. 
